Reflux Company Announces Appointment of Inaugural Independent Board BREMERTON, WA, UNITED STATES, September 19, 2025 Veteran experts bring Deep Industry Experience, Commercial Launch Success, and Financial […]
Increased Stretta Production and Enhanced Supply Chain Eases Shipping Backlog Restech is pleased to announce that we have resolved the supply chain issues involving our Stretta […]
Restech Partners with Nissha Medical Technologies to Double Production Capacity of Stretta Catheters in 2024 HOUSTON, TX, UNITED STATES, September 12, 2023 Restech, a leader in […]
Restech and Medstent Surgery Announce Strategic Partnership to Expand Distribution Throughout Central America This collaboration marks a significant milestone in Restech’s mission to extend its medical […]
Minimally Invasive Stretta Therapy Gains Momentum as HCSC BCBS Adds Coverage for 16 Million New Patients We’ve all been there. In our doctor’s office, or […]
Minimally Invasive Stretta Antireflux Procedure Accessible to Millions more Patients If your doctor says a certain drug or therapy would be beneficial in treating you, […]
A new study on Stretta anti-reflux therapy was recently published in Frontline Gastroenterology, reinforcing the value and safety of Stretta as a viable option for many […]
ABSTRACT One potential option for the management of refractory gastro-esophageal reflux disease (GERD) is the delivery of radiofrequency energy to the gastro-esophageal junction (Stretta). This endoscopic […]
Mederi Therapeutics announced highlights of educational activities on Stretta Therapy for Gastroesophageal Reflux Disease (GERD) that took place at Digestive Disease Week® 2017 (DDW 2017). The activities included a presentation on "Unmet Needs in GERD Treatment", presented by Dr. Ronnie Fass and Professor Jan Tack. The presentation featured data from the new Stretta Meta-Analysis as well as data on mechanism and GERD outcome measures.